Retina department, Asociación para Evitar le Ceguera en México IAP, México City, México.
Retina. 2023 Sep 1;43(9):1433-1447. doi: 10.1097/IAE.0000000000003773.
To organize, categorize, and create a quick reference guide for the use of intravitreal antibiotic alternatives to the standard combination of vancomycin and ceftazidime for the treatment of endophthalmitis.
A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. The authors searched for all available information regarding intravitreal antibiotics in the last 21 years. Manuscripts were selected according to relevance, level of information, and the available data regarding intravitreal dose, potential adverse effects, bacterial coverage, and relevant pharmacokinetic information.
The authors included 164 of 1810 manuscripts. The antibiotics were classified according to their class into fluoroquinolones, cephalosporins, glycopeptide and lipopeptide, penicillins and beta-lactams, tetracyclines, and miscellaneous. The authors also included information regarding intravitreal adjuvants for the treatment of endophthalmitis and one ocular antiseptic.
The treatment of infectious endophthalmitis is a therapeutic challenge. The current review summarizes the properties of possible intravitreal antibiotic alternatives that should be considered in cases of suboptimal response to initial treatment.
为治疗眼内炎,对万古霉素和头孢他啶标准联合用药以外的眼内抗生素替代药物的使用进行组织、分类并创建快速参考指南。
本研究按照系统评价和荟萃分析的首选报告项目进行了系统回顾。作者检索了过去 21 年中所有关于眼内抗生素的可用信息。根据相关性、信息水平以及有关眼内剂量、潜在不良反应、细菌覆盖范围和相关药代动力学信息的可用数据选择了文献。
作者纳入了 1810 篇文献中的 164 篇。根据其类别,抗生素被分为氟喹诺酮类、头孢菌素类、糖肽和脂肽类、青霉素和β-内酰胺类、四环素类和其他类。作者还包括了用于治疗眼内炎的眼内辅助药物和一种眼部防腐剂的信息。
感染性眼内炎的治疗是一个治疗挑战。本综述总结了在初始治疗反应不佳的情况下,应考虑的可能的眼内抗生素替代药物的特性。